(Q48391122)

11 February 2018

title

Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage. (English)

1 reference

11 February 2018

2

Roberta Rizzo

1 reference

11 February 2018

author name string

Enrico Fainardi

1

1 reference

11 February 2018

Angelica Lupato

3

1 reference

11 February 2018

Vania Ramponi

4

1 reference

11 February 2018

Giuseppe De Santis

5

1 reference

11 February 2018

Francesco Garofano

6

1 reference

11 February 2018

Marina Stignani

7

1 reference

11 February 2018

Carmine Tamborino

8

1 reference

11 February 2018

Massimiliano Castellazzi

9

1 reference

11 February 2018

Ilaria Casetta

10

1 reference

11 February 2018

Olavio Roberto Baricordi

11

1 reference

11 February 2018

publication date

1 January 2010

1 reference

11 February 2018

Acta Neurochirurgica. Supplementum

published in

1 reference

11 February 2018

volume

106

1 reference

11 February 2018

page(s)

141-145

1 reference

11 February 2018

Measurements of acute cerebral infarction: a clinical examination scale

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_25

Early hemorrhage growth in patients with intracerebral hemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_25

HLA-G: from biology to clinical benefits

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_25

Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_25

Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_25

Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_25

The ABCs of measuring intracerebral hemorrhage volumes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_25

Biology and functions of human leukocyte antigen-G in health and sickness

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_25

Quantification and identification of soluble HLA-G isoforms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_25

Theoretical and experimental optimization of laser speckle contrast imaging for high specificity to brain microcirculation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_25

HLA-G in the nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_25

Mechanisms of brain injury after intracerebral haemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_25

10.1007/978-3-211-98811-4_25

31 March 2020

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018